Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors

Cancer Research

Volumn 64, Issue 16, 2004, Pages 5587-5591

  Pentland, Alice P ^a,b   Scott, Glynis ^a   VanBuskirk, JoAnne ^a   Tanck, Carol ^a   LaRossa, Gina ^a   Brouxhon, Sabine ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CASPASE 3; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE DELETION; KERATINOCYTE; KNOCKOUT MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TUMOR PROMOTION; TUMOR VOLUME; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CELL DIVISION; CYCLOOXYGENASE 2; FEMALE; ISOENZYMES; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED HRS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 4143101590     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1045     Document Type: Article

References (36)

1. Ananthaswamy HN. Ultraviolet light as a carcinogen. In: Bowden GT, Fischer SM, editors. Comprehensive toxicology. New York: Elsevier; 1997. p. 253-70.
2. DeGruij F, van Kranen HJ, Mullenders LHF. UV-induced DNA damage, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B 2001;63:19-27.
3. Bruce A, Brodland DG. Overview of skin cancer detection and prevention for the primary care physician. Mayo Clin Proc 2000;75:491-500.
4. Strayer SM, Reynolds PL. Diagnosing skin malignancy: assessment of predictive clinical criteria and risk factors. J Fam Pract 2003;52:210-8.
5. Pentland AP. Arachidonic acid metabolism. In: Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1998.
6. Furstenberger G, Marks F. The role of eicosanoids in normal, hyperplastic and neoplastic skin. In: Ruzicka T, editor. Eicosanoids in the skin. Boca Raton, FL: CRC Press; 1990. p. 107-24.
7. Pentland AP, Mahoney M, Jacobs SC, Holtzman MJ. Enhanced prostaglandin synthesis after ultraviolet injury is mediated by endogenous histamine stimulation. J Clin Investig 1990;86:566-74.
8. Konger R, Malaviya R, Pentland AP. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim Biophys Acta 1998;1401:221-34.
9. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthase (cyclooxygenases-1 and -2). J Biol Chem 1996;271:33157-60.
10. Athar M, An KP, Morel KD, et al. Ultraviolet B (UVB)-induced COX-2 expression in murine skin: an immunohistochemical study. Biochem Biophys Res Comm 2001;280:1042-7.
11. Buckman SY, Gresham A, Hale P, et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998;19:723-9.
12. Chen W, Tang Q, Gonzolews MS, Bowden GT. Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes. Oncogene 2001;20:3921-6.
13. Church RD, Fleshman JW, McLeod HL. Cyclooxygenase 2 inhibition in colorectal cancer therapy. Br J Surg 2003;90:1055-67.
14. Pruthi RS, Derksen E, Gaston K. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: A review. J Urol 2003;169:2352-9.
15. Fischer SM, Lo H, Gordon GB, et al. Chemoprotective activity of Celecoxib, a specific cyclooxegenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 1999;25:231-40.
16. Marks F, Furstenberger G. Cancer chemoprevention through interruption of multi-stage carcinogenesis: lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur J Cancer 2000;36:314-29.
17. Marks F, Muller-Decker K, Furstenberger G. A casual relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology 2000;153:11-26.
18. Pentland AP, Schoggins JW, Scott GA, Khan KNM, Han R. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999;20:1939-44.
19. Muller-Decker K, Kopp-Schneider A, Marks F, Seibert K, Furstenberger G. Localization of prostaglandin H synthase isozymes in murine epidermal tumors: suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2. Mol Carcinog 1998;23:36-44.
20. Chulada PC, Morrow TB, Mahler JF, et al. Genetic disruption of Ptgs-1, as well as of Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res 2000;60:4705-8.
21. Tiano HF, Loftin CD, Akunda J, et al. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse tumorigenesis. Cancer Res 2002;62:3395-401.
22. Tripp CS, Blomme EAG, Hardy MM, LaCelle P, Pentland AP. Epidermal COX-2 induction after ultraviolet irradiation: Suggested mechanism for the role of COX-2 inhibition in photoprotection. J Investig Dermatol 2003;121:853-61.
23. Langenbach R, Morham SG, Tiano H, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995;83:483-92.
24. DeGruijl F, Forbes PD. UV-induced skin cancer in a hairless mouse model. Bioessays 1995;17:651-60.
25. Djabali K, Christiano AM. Hairless is a nuclear matrix associated protein with a putative chromatin remodeling function. J Investig Dermatol 2002;7:1330.
26. Panteleyev AA, Paus R, Ahmad H, Sundberg JP, Christiano AM. Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp Dermatol 1998;7:249-67.
27. Brouxhon SM, Prasad AV, Joseph SA, Felten DL. Localization of corticotropin-releasing factor in primary and secondary lymphoid organs of the rat. Brain Behav Immun 1998;12:107-22.
28. Bradley J, editor. Distribution-free statistical tests. Englewood Cliffs, NJ: Prentice-Hall; 1968.
29. Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K. Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci USA 2001;98:7629-34.
30. Bol DK, Rowley RB, Ho CP, et al. Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development. Cancer Res 2001;62:2516-21.
31. Makinen M, Stenback F. Skin tumor development and keratin expression in different experimental models. Relation to inducing agent and target tissue structure. Exp Toxicol Pathol 1998;50:199-208.
32. Dumaz N, van Kranen, HJ, de Vries A, et al. The role of UVB light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice. Carcinogenesis 1997;15:897-904.
33. Ravi R, Bedi A. Potential methods to circumvent blocks in apoptosis in lymphomas. Curr Opin Oncol 2002;14:490-503.
34. Thornalley PJ. Isothiocyanates: mechanism of cancer chemopreventive action. Anti-Cancer Drugs 2002;13:331-8.
35. Kim R, Tanabe K, Emi M, et al. Inducing cancer cell death by targeting transcription factors. Anti-Cancer Drugs 2003;14:3-11.
36. Chetty R. p27 protein and cancers of the gastrointestinal tract and liver: an overview. J Clin Gastroenterol 2003;37:23-7.